Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-25-004075
Filing Date
2025-11-14
Accepted
2025-11-14 17:01:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7072
2 jfa.htm EX-99.1 7000
3 subsidiaries.htm EX-99.2 2916
  Complete submission text file 0000905148-25-004075.txt   19217
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-45947 | Film No.: 251487924
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1-13-1 NIHONBASHI CHUO-KU TOKYO Japan 103-8645
Business Address 1-13-1 NIHONBASHI CHUO-KU TOKYO Japan 103-8645 81-3-5255-1000
NOMURA HOLDINGS INC (Filed by) CIK: 0001163653 (see all company filings)

EIN.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)